EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte StudieOpen Access

Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

Jessica C Hassel, Sophie Piperno-Neumann, Piotr Rutkowski, Jean-Francois Baurain, Max Schlaak, Marcus O Butler, Ryan J Sullivan, Reinhard Dummer, John M Kirkwood, Marlana Orloff, Joseph J Sacco, Sebastian Ochsenreither und 17 weitere

New England Journal of Medicine · 14.12.2023 · 389 (24) · 2256-2266

DOI: 10.1056/nejmoa2304753 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 14.12.2023. Verfasst von Jessica C Hassel und 28 weiteren Autor:innen. Beteiligte Einrichtung: From the University Hospital Heidelberg, Heidelberg (J.C.H.), the Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian Unive…. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Melanoma, Uveal Neoplasms, Recombinant Fusion Proteins. Die Arbeit wurde bisher 312-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsMelanomaUveal NeoplasmsRecombinant Fusion ProteinsAdultHumansHLA-A AntigensUveal Melanoma

Substanzen

HLA-A AntigenstebentafuspRecombinant Fusion Proteins

Autor:innen und Institutionen

  • From the University Hospital Heidelberg, Heidelberg (J.C.H.), the Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University of Munich, Munich (M.S.), and the Department of Dermatology, Ven…

Förderung

  • NCI NIH HHS

Zitieren

APA

Hassel, J. C., Piperno-Neumann, S., Rutkowski, P., Baurain, J. F., Schlaak, M., Butler, M. O., Sullivan, R. J., Dummer, R., Kirkwood, J. M., Orloff, M., Sacco, J. J., Ochsenreither, S., Joshua, A. M., Gastaud, L., Curti, B., Piulats, J. M., Salama, A. K. S., Shoushtari, A. N., Demidov, L., …, & Nathan, P. (2023). Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma. New England Journal of Medicine, 389(24), 2256-2266. https://doi.org/10.1056/nejmoa2304753

Vancouver

Hassel JC, Piperno-Neumann S, Rutkowski P, Baurain JF, Schlaak M, Butler MO, et al. Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma. New England Journal of Medicine. 2023;389(24):2256-2266. doi:10.1056/nejmoa2304753

BibTeX
@article{Hassel2023,
  author = {Hassel, Jessica C and Piperno-Neumann, Sophie and Rutkowski, Piotr and Baurain, Jean-Francois and Schlaak, Max and Butler, Marcus O and Sullivan, Ryan J and Dummer, Reinhard and Kirkwood, John M and Orloff, Marlana and Sacco, Joseph J and Ochsenreither, Sebastian and Joshua, Anthony M and Gastaud, Lauris and Curti, Brendan and Piulats, Josep M and Salama, April K S and Shoushtari, Alexander N and Demidov, Lev and Milhem, Mohammed and Chmielowski, Bartosz and Kim, Kevin B and Carvajal, Richard D and Hamid, Omid and Collins, Laura and Ranade, Koustubh and Holland, Chris and Pfeiffer, Constance and Nathan, Paul},
  title = {Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {24},
  pages = {2256--2266},
  doi = {10.1056/nejmoa2304753}
}
Kostenlos starten →